The evolution of the treatment of non–small cell lung cancer: A shift in surgical paradigm to a more individualized approach
The Journal of Thoracic and Cardiovascular Surgery · 2025-03 · 169 (3) · 737-744.e2
DOI: 10.1016/j.jtcvs.2024.07.040 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Thoracic and Cardiovascular Surgery, 2025-03. Verfasst von Tong Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China; Institute o…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Pneumonectomy, Precision Medicine. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: Shanghai Xuhui District Central Hospital, National Key Clinical Specialty Discipline Construction Program of China, Ministry of Industry and Information Technology of the People's Republic of China.
Abstract (Originalsprache)
Surgical treatment is an integral part of the comprehensive therapeutic methods for lung cancer, especially for early-stage non-small cell lung cancer (NSCLC). With a deeper understanding of the disease, we found that lung cancer is more commonly detected in young females. For regions of Asia, more lung cancer has been detected in early-stage GGO-dominant non-smokers. Therefore, surgical strategies have also been reformed commensurate with the shift of the disease spectrum. However, the pursuit of lung-sparing individualized approaches has raised worldwide attention. Suitable surgical treatment within the curative time window is recommended to maximize the long-term benefit. This article summarizes the shift in surgical treatment for small NSCLCs and hopes to enlighten further innovations to fill in the gaps between the unmet needs and a more individualized approach.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China; Institute of Thoracic Oncology, Fudan University, Shanghai, China; Department of…
Förderung
- Shanghai Xuhui District Central Hospital
- National Key Clinical Specialty Discipline Construction Program of China
- Ministry of Industry and Information Technology of the People's Republic of China
- Shanghai Technology Innovation Project
Zitieren
APA
Li, T., Zhang, Y., Fu, F., & Chen, H. (2025). The evolution of the treatment of non–small cell lung cancer: A shift in surgical paradigm to a more individualized approach. The Journal of Thoracic and Cardiovascular Surgery, 169(3), 737-744.e2. https://doi.org/10.1016/j.jtcvs.2024.07.040
Vancouver
Li T, Zhang Y, Fu F, Chen H. The evolution of the treatment of non–small cell lung cancer: A shift in surgical paradigm to a more individualized approach. The Journal of Thoracic and Cardiovascular Surgery. 2025;169(3):737-744.e2. doi:10.1016/j.jtcvs.2024.07.040
BibTeX
@article{Li2025,
author = {Li, Tong and Zhang, Yang and Fu, Fangqiu and Chen, Haiquan},
title = {The evolution of the treatment of non–small cell lung cancer: A shift in surgical paradigm to a more individualized approach},
journal = {The Journal of Thoracic and Cardiovascular Surgery},
year = {2025},
volume = {169},
number = {3},
pages = {737--744.e2},
doi = {10.1016/j.jtcvs.2024.07.040}
}
EUVIMED